share_log

B of A Securities Maintains Neutral on Amgen, Raises Price Target to $330

Benzinga ·  Aug 8 01:08  · Ratings

B of A Securities analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $325 to $330.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment